Alyeska Investment Group L.P. Invests $36.98 Million in Envista Holdings Co. (NYSE:NVST)
Alyeska Investment Group L.P. Invests $36.98 Million in Envista Holdings Co. (NYSE:NVST)
Alyeska Investment Group L.P. bought a new position in Envista Holdings Co. (NYSE:NVST – Get Rating) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 759,230 shares of the company's stock, valued at approximately $36,982,000. Alyeska Investment Group L.P. owned about 0.47% of Envista as of its most recent filing with the Securities and Exchange Commission.
Alyeska Investment Group L.P.在第一季度购买了enVista Holdings Co.(纽约证券交易所代码:NVST-GET Rating)的新头寸,根据该公司最近向美国证券交易委员会(Securities And Exchange Commission)披露的信息。该机构投资者买入了759,230股该公司股票,价值约36,982,000美元。截至最近提交给美国证券交易委员会的文件,Alyeska Investment Group L.P.持有enVista约0.47%的股份。
Other large investors have also made changes to their positions in the company. Point72 Hong Kong Ltd acquired a new position in Envista during the 1st quarter worth about $1,812,000. Sandler Capital Management acquired a new position in Envista during the 1st quarter worth about $8,305,000. Eaton Vance Management lifted its position in Envista by 7.2% during the 1st quarter. Eaton Vance Management now owns 2,187,720 shares of the company's stock worth $106,563,000 after buying an additional 147,127 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Envista by 12.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 619,623 shares of the company's stock worth $30,181,000 after buying an additional 67,760 shares in the last quarter. Finally, Connacht Asset Management LP lifted its position in Envista by 11.1% during the 1st quarter. Connacht Asset Management LP now owns 43,538 shares of the company's stock worth $2,121,000 after buying an additional 4,333 shares in the last quarter.
其他大型投资者也改变了他们在该公司的头寸。Point72 Hong Kong Ltd于第一季度收购了enVista的新头寸,价值约1,812,000美元。桑德勒资本管理公司在第一季度收购了enVista的一个新头寸,价值约8,30.5万美元。伊顿·万斯管理公司在第一季度将其在enVista的头寸提高了7.2%。伊顿·万斯管理公司现在拥有2187,720股该公司股票,价值106,563,000美元,上个季度又购买了147,127股。高盛股份有限公司在第一季度将其在恩维斯塔的持仓提高了12.3%。高盛股份有限公司现在持有该公司619,623股股票,价值30,181,000美元,该公司在上个季度又购买了67,760股。最后,Connacht Asset Management LP在第一季度将其在enVista的头寸提高了11.1%。Connacht Asset Management LP现在拥有43,538股该公司股票,价值2,121,000美元,上个季度又购买了4,333股。
Envista Trading Down 3.9 %
EnVista股价下跌3.9%
Shares of NVST stock traded down $1.50 on Tuesday, reaching $36.68. The company had a trading volume of 28,262 shares, compared to its average volume of 1,563,524. The company has a current ratio of 1.11, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. The stock has a market cap of $5.99 billion, a PE ratio of 21.99, a PEG ratio of 1.50 and a beta of 1.54. The company has a 50-day moving average of $38.81 and a 200-day moving average of $41.90. Envista Holdings Co. has a 12 month low of $34.75 and a 12 month high of $52.03.
周二,NVST股价下跌1.50美元,至36.68美元。该公司的成交量为28,262股,而其平均成交量为1,563,524股。该公司的流动比率为1.11,速动比率为0.88,债务权益比率为0.22。该股市值59.9亿美元,市盈率21.99倍,聚乙二醇率1.50倍,贝塔系数1.54。该公司的50日移动均线切入位在38.81美元,200日移动均线切入位在41.90美元。EnVista Holdings Co.股价跌至34.75美元的12个月低点,以及52.03美元的12个月高点。
Analyst Ratings Changes
分析师评级发生变化
Envista Company Profile
EnVista公司简介
(Get Rating)
(获取评级)
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.
EnVista控股公司及其子公司在美国、中国和国际上从事牙科产品的开发、销售和营销。该公司经营两个细分市场:专业产品与技术和设备与耗材。该公司的专业产品与技术部门为口腔外科医生、口腔修复医生和牙周科医生提供牙齿植入系统、引导手术系统、生物材料以及预制和定制的义齿;Damon、Insignia、AOA和Spark品牌的托槽和电线、管和带、弓丝、透明矫正器、数码正畸治疗、固位体和其他正畸实验室产品。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Envista (NVST)
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
- 3 Energy Stocks Nearing Breakouts From Cup-Shaped Patterns
- Do These Dividend Achievers Deserve A Place In Your Portfolio?
- 免费获取StockNews.com在enVista上的研究报告(NVST)
- 这就是现在对标准普尔500指数的预期
- 关于甲骨文的FQ1报告,你需要知道的两件事
- 波动市场的三只价值股
- 3个能源类股接近突破杯形格局
- 这些股息获得者值得在你的投资组合中占有一席之地吗?
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Get Rating).
想看看还有哪些对冲基金持有NVST吗?访问HoldingsChannel.com获取enVista Holdings Co.(纽约证券交易所代码:NVST-GET Rating)的最新13F文件和内幕交易信息。
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
接受《EnVista日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对enVista和相关公司的最新新闻和分析师评级的每日简要摘要。